News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Monument Therapeutics Launches First Clinical Study of MT1988, a Novel Treatment...

Nov 27th 2024
Monument Therapeutics, a precision neuroscience company, today announced the first participant has been successfully dosed in its Phase I clinical study of MT1988, a novel treatment targetin...
Read More

Report: Preparation, Characterisation and in vitro Assessment of siRNA-loaded Li...

Oct 30th 2024
Medicines Discovery Catapult is developing new ways to characterise the physical properties of nanoparticles using single-molecule localisation microscopy.
Read More

New NHC Service launched to accelerate gene therapy development

Sep 26th 2024
The National Horizons Centre at Teesside University has launched VecTUs, a new research-grade BioVector production service.
Read More

Tech Pioneer Awarded to Manchester Entrepreneur

Jul 5th 2024
Dr. Farid Khan, CEO of PharmaKure was awarded Asian Tech Pioneer in his work in Biotech.
Read More

University launches new biotech spin-out company

Jun 28th 2024
The University of Liverpool has launched a new biotech spin-out company to develop novel therapeutic drugs for the treatment of cancer and fibrotic diseases.
Read More

Announcing Pharmora’s first masterclass blog series: Happy Birthday HGR!

Jun 28th 2024
On the first anniversary of the finalisation of the HGR regulations in China, Pharmora has put together a Masterclass of 3 blogs, aimed to help those of us working in clinical development un...
Read More

Precision neuroscience company Monument Therapeutics announces £1.5m funding to...

Apr 22nd 2024
Monument Therapeutics, a precision neuroscience company, today announced new funding of £1.5 million from a combination of equity investment and non-dilutive grant as part of the Innovate U...
Read More

New University of Liverpool spin-out developing novel adult stem cell-based Ther...

Feb 15th 2024
The University of Liverpool has launched a new spin-out company, TrophiCell, that has developed a revolutionary approach to harness the therapeutic potential of adult Mesenchymal Stem Cells ...
Read More

PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the tre...

Jan 5th 2024
Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease
Read More

Biocair helps FibroFind fast-track vital fibrosis drug development

Nov 7th 2023
The experienced life science logistics company, Biocair, provides critical logistics support to a cutting-edge research project into drugs that can treat, and prevent, one of the world’s m...
Read More

PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients wit...

Oct 24th 2023
PharmaKure submits MHRA CTA for Phase 2a Clinical Trial of PK051 in patients with mild cognitive impairment Clinical Trial Application filed for combined drug targeting amyloid deposits as...
Read More

First patient dosed in Phase 1 Trial

Oct 23rd 2023
Iksuda Therapeutics announces first patient dosed in Phase 1 trial of IKS014 in patients with advanced solid tumours that express HER2
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners